ARS Pharmaceuticals, Inc. (NasdaqGM: SPRY)
Health Care · Biotechnology · US
$4.18
-1.18% today · -61.3% 1Y
ARS Pharmaceuticals, Inc. (NasdaqGM: SPRY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $420.66M and employs 195 people.
Over the last twelve months the share price has lost 61.3%, trading between 3.99 and 13.15.
Tweenvest scores ARS Pharmaceuticals, Inc. across four factors: quality 49/100, value 52/100. Its strongest factor is value.
SPRY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $420.66M
- Revenue (TTM)
- $116.93M
- P/E
- —
- EPS
- -2.18
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- $13.15
- 52-week low
- $3.99
- Avg volume (3M)
- —
- Shares outstanding
- 99.45M
- Employees
- 195
- Next earnings
- —
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
- ISIN
- US82835W1080
- Founded
- 2015
- Listed since
- Dec 4, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Edding Genor Group Holdings LimitedSEHK: 6998 | $427.74M | HK$1.70 | +0.29% |
| Editas Medicine, Inc.NasdaqGS: EDIT | $422.35M | $2.75 | -5.17% |
| Hubei Goto Biopharm Group Co., Ltd.SZSE: 300966 | $422.02M | CN¥24.75 | -3.70% |
| Avacta Group PlcAIM: AVCT | $421.93M | £0.64 | -2.29% |
| Yantai Zhenghai Biotechnology Co., Ltd.SZSE: 300653 | $413.71M | CN¥15.59 | -2.74% |
| Myriad Genetics, Inc.NasdaqGS: MYGN | $412.25M | $4.20 | -2.55% |
| AVITA Medical, Inc.NasdaqCM: RCEL | $408.54M | $13.37 | +1.21% |
| Guangdong VTR Bio-Tech Co., Ltd.SZSE: 300381 | $406.47M | CN¥5.67 | -0.35% |
Figures last refreshed Oct 11, 2026.